Walleye Trading LLC Ocular Therapeutix, Inc Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $21,164 - $35,151	-4,601 Reduced 9.25%	45,115 $232,000
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $138,707 - $311,719	49,716 New	49,716 $262,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $18,740 - $28,518	-3,880 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $23,900 - $46,831	3,880 New	3,880 $27,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $54,872 - $81,121	-5,657 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $75,973 - $108,388	5,657 New	5,657 $80,000
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $131,744 - $176,673	-17,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $83,593 - $160,205	17,900 New	17,900 $149,000
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $4,094 - $7,522	-1,058 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $5,734 - $7,395	1,058 New	1,058 $7,000

172

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $764M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.